Medacta International

Castel San Pietro, Switzerland  All Switzerland companies → Founded 1999
Medical Device / Hardware Specialty-Focused AI
Orthopedics
Radiology & Imaging AI Surgical AI
Publicly Traded — Publicly traded with a market capitalization of $3.86B as of April 2, 2026. Prior to IPO, raised an undisclosed amount over 4 rounds.

Products

MyShoulder Planner (5.3SSWPL)
Medacta International
Radiology & Imaging AI
MyShoulder Planner by Medacta International is an AI-powered software for personalized 3D preoperative planning of total shoulder replacement surgery, utilizing CT scans to optimize implant positioning and generate patient-specific guides.

See all 1 product →

About Medacta International

Medacta International is a global leader in the orthopedic and neurosurgical medical device industry, dedicated to advancing patient care through innovative products and surgical techniques. The company specializes in joint replacement (hip, knee, shoulder), spine surgery, and sports medicine, with a strong emphasis on minimally invasive approaches such as their Anterior Minimally Invasive Surgery (AMIS) technique for hip replacements. Their portfolio includes advanced implants and instruments, complemented by cutting-edge technologies like the MySolutions personalized ecosystem. This ecosystem offers surgeons highly personalized pre-operative planning, patient-matched surgical guides, and 3D planning tools across various anatomical regions.

Furthermore, Medacta is at the forefront of integrating augmented reality (AR) into surgical workflows, exemplified by platforms such as NextAR Shoulder and NextAR Spine. These AR solutions are designed to enhance surgical accuracy and outcomes by providing real-time guidance and complementing their comprehensive implant systems. Beyond technological innovation, Medacta is deeply committed to medical education through the M.O.R.E. Institute, offering comprehensive programs to support surgeons in adopting new techniques and optimizing patient pathways. The company’s overarching vision is to improve patient well-being and contribute to healthcare sustainability by developing efficient and economically viable solutions.

What Physicians Need to Know

Core Specialization
Medacta International specializes in Augmented Reality (AR) surgical platforms for orthopedic procedures, including Total Knee Arthroplasty (TKA), Shoulder Arthroplasty, and Spine Surgery.
Technology Stack
Their NextAR platform leverages AR Smart Glasses for real-time visualization, advanced 3D planning tools based on CT images, and a proprietary infrared single-use tracking system (NextAR TS). It also incorporates Artificial Intelligence (AI) and Machine Learning (ML) for enhanced pre-operative planning and analysis.
Key Differentiator: Personalized 3D Planning
The platform enables patient-specific 3D planning, allowing surgeons to design optimal surgical strategies based on each patient's unique anatomy and biomechanics.
Key Differentiator: Real-time Intraoperative Guidance
NextAR provides real-time surgical guidance superimposed onto the operative field via smart glasses, enhancing precision and enabling data-driven decision-making.
Key Differentiator: Unique Single-Use Tracking System
The NextAR TS is a proprietary infrared single-use tracking system that offers real-time instrument guidance and accurate implant positioning without compromising O.R. logistics.
Key Differentiator: Healthcare Sustainability & Cost-Effectiveness
The NextAR platform is designed with healthcare sustainability in mind, featuring limited capital investment and low per-case costs, making it an optimal solution for Ambulatory Surgery Centers (ASCs).
Key Differentiator: Soft Tissue Tracking (TKA)
For Total Knee Arthroplasty, the NextAR TKA Application uniquely tracks 3D soft tissue behavior in real-time during surgery, an advancement over systems that only track bone movement.
Key Differentiator: NextAR Rod Optimizer (Spine)
For spine surgery, the NextAR Rod Optimizer provides a sustainable and personalized solution for intraoperative planning and real-time selection of pre-bent rods, potentially eliminating the need for manual rod bending and reducing risks.
Physician Tip

For physicians, Medacta's NextAR platform offers enhanced precision and accuracy in orthopedic surgeries through real-time augmented reality guidance and personalized 3D planning. It enables data-driven decision-making and allows for personalized adjustments based on each patient's unique anatomy and biomechanics. The system is designed to improve surgical workflow and efficiency, potentially leading to improved patient outcomes and faster rehabilitation. Its cost-effectiveness, with low capital investment and per-case costs, makes it an attractive option, especially for ASCs. The ability to track real-time soft tissue behavior in TKA and the innovative rod optimization for spine surgery provide advanced capabilities for complex procedures. Medacta also emphasizes tailored education programs to support surgeons in adopting these new technologies.

The NextAR Augmented Reality Surgical Platform is a core component of Medacta's broader 'MySolutions Personalized Ecosystem,' an advanced network of digital solutions aimed at improving patient outcomes, healthcare efficiency, and sustainability. The platform is designed to host software for multiple applications (NextAR Knee, NextAR Shoulder, NextAR Spine), offering a single hardware system for diverse orthopedic procedures.

Products by Medacta International

1 product in the directory

MyShoulder Planner (5.3SSWPL)
Medacta International
Radiology & Imaging AI
MyShoulder Planner by Medacta International is an AI-powered software for personalized 3D preoperative planning of total shoulder replacement surgery, utilizing CT scans to optimize implant positioning and generate patient-specific guides.

What the Web Says

Medacta International generally receives mixed reviews as an employer, with some employees praising its opportunities and work environment, while others express concerns about management, communication, and training. Product reviews for Medacta's medical devices are limited, but some highlight the quality of their knee replacement systems. There are also serious allegations regarding product defects and a cover-up concerning their Mectalif Anterior lag screw system for spinal fusion.

Overall: Mixed

Strengths

  • Great place to work with many different opportunities and avenues for career growth.
  • Inclusive group of people and good collaboration between divisions.
  • Fairly good pay and benefits.
  • Stable work environment.
  • Good products, with some noting the quality of their patient-specific cutting blocks and knee systems.
  • Work-life balance is rated above average.

Limitations

  • Lack of training and high expectations from management with unrealistic goals.
  • Poor communication between employees and management.
  • Indecisive management and constant changes on a daily basis.
  • Concerns about lower-than-expected commission for sales representatives with no base pay.
  • Allegations of product defects, malfunctions, and a cover-up regarding the Mectalif Anterior lag screw system, leading to patient harm.
  • Some employees report a lack of opportunities for growth within the company.

Based on reviews from: Indeed.com, Which Medical Device, Reddit, MAUDE Adverse Event Report

Last updated: 2026-07-18

Videos

News, demos, and interviews about Medacta International.

Loading videos...

Videos load interactively. If none appear, search YouTube for Medacta International →

View all on YouTube

Press & Coverage

Medacta International
Medacta Expands NextAR Shoulder to Glenoid Deformity and Revision Cases in the U.S.
Medacta announced the expansion of its NextAR Shoulder augmented reality surgical platform to include glenoid deformity and revision cases in the U.S. in April 2026.
2026-04
Medacta International
Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance
Medacta Group SA reported record results for Full Year 2025, with revenue accelerating to Euro 683.8 million, an increase of 18.5% in constant currency, and upgraded its mid-term guidance.
2026-03
EQS News
Medacta selected as partner for groundbreaking international research project
Medacta Group SA announced its selection as a partner in an international research project aimed at recreating dinosaurs from preserved DNA samples, specifically developing an orthopedic hip prosthesis for a T-Rex.
2026-04
Medacta International
Medacta Group reports continued significant above-market revenue growth of 18.5% in constant currency in 2025
Medacta Group SA reported continued significant above-market revenue growth of 18.5% in constant currency for 2025, reaching Euro 683.8 million, driven by strong performance across all geographic markets and business lines.
2026-02
Medacta International
Medacta Launches QuickStitch and Expands Fixation Solutions at AGA 2025
Medacta launched QuickStitch and expanded its fixation solutions at AGA 2025, introducing new products like DrawTight, ActiFlip, ActiFlip Cinch, and Knotless PEEK CF Push-In, emphasizing personalized solutions in sports medicine.
2025-09
Medacta International
Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution
Medacta Group SA partnered with THINK Surgical to integrate its TMINIu00ae Miniature Robotic System with Medacta's GMK Sphere and GMK SpheriKA implants for robotic total knee replacement surgery in the US market.
2024-08
Medacta International
Medacta Announces First Anatomic Shoulder Replacement with the NextAR Augmented Reality Surgical Application in the United States
Medacta Group SA announced the first anatomic shoulder cases completed in the United States using its NextAR Augmented Reality Surgical Application in combination with the Medacta Shoulder System.
2024-11
Medacta International
Medacta further expands in Rancate, Switzerland, doubling its production capability to support the future growth
Medacta announced the expansion of its facilities in Rancate and Castel San Pietro, Switzerland, to double its production capability and support future growth, with a new distribution center in Memphis, Tennessee, already operational.
2023-11

Frequently Asked Questions

Medacta International offers the NextAR Augmented Reality Surgical Platform, which includes applications for Total Knee Arthroplasty (TKA), Shoulder, and Spine procedures. This platform leverages AI and machine learning for personalized pre-operative planning, real-time surgical guidance, and advanced analysis of soft tissue behavior during surgery.
Medacta operates under a Corporate Compliance Programme aligned with the MedTech Europe Code of Ethics and respects local regulations, such as the AdvaMed Code in the USA. Their NextAR TKA application, for instance, has received FDA clearance, demonstrating adherence to key regulatory standards.
Medacta's NextAR platform is designed to require a low upfront capital investment from clinics and hospitals, coupled with a low cost per procedure. This model, which includes single-use instrumentation, aims to provide economic benefits and is particularly suited for Ambulatory Surgery Centers (ASCs).
Medacta provides extensive support through its M.O.R.E. Institute, which offers comprehensive and tailored medical education programs. They emphasize strong collaboration with surgeons and state that with Medacta, the surgeon is never alone, ensuring ongoing guidance and training.
Yes, Medacta International actively collaborates with expert surgeons globally for product development and has formed strategic partnerships, such as with THINK Surgical, to expand its robotic total knee arthroplasty solutions. These collaborations are part of their MySolutions Personalized Ecosystem.
Medacta International demonstrates strong financial stability with consistent revenue growth and an increasing adjusted EBITDA margin, as reported in their recent financial statements. They are a global key player operating in over 70 countries and continue to invest significantly in R&D and cutting-edge technologies like AI to drive innovation and sustainable growth.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.